Concepedia

Publication | Open Access

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

DOIFull Paper Access

494

Citations

21

References

2022

Year

Robin Kate Kelley, Lorenza Rimassa, Ann‐Lii Cheng, Ahmed O. Kaseb, Shukui Qin, Andrew X. Zhu, Stephen L. Chan, Tamar Melkadze, Wattana Sukeepaisarnjaroen, Gontran Verset,
The Lancet Oncology

Abstract

Exelixis and Ipsen.

References

YearCitations

Page 1